Evasion of innate immunity by parasitic protozoa

Nature Immunology

Volumn 3, Issue 11, 2002, Pages 1041-1047

  Sacks, David ^a   Sher, Alan ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; LYSOSOME ENZYME; TOXIN;

ANTIGEN PRESENTATION; CELL ACTIVATION; CELL COMPARTMENTALIZATION; CELL FUNCTION; CHRONIC DISEASE; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; EUKARYOTE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOREGULATION; INFECTION; INTRACELLULAR KILLING; LYSIS; NONHUMAN; PARASITE; PATHOGENESIS; PHAGOSOME; PRIORITY JOURNAL; PROTOZOAL INFECTION; REVIEW; SIGNAL TRANSDUCTION; VERTEBRATE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, PROTOZOAN; CATTLE; CATTLE DISEASES; CHILD; DENDRITIC CELLS; HOST-PARASITE RELATIONS; HUMANS; IMMUNITY, NATURAL; INSECT VECTORS; INTERLEUKIN-12; LEISHMANIA; MICE; PHAGOSOMES; PROTOZOA; PROTOZOAN INFECTIONS; PROTOZOAN INFECTIONS, ANIMAL; SIGNAL TRANSDUCTION; TOXOPLASMA; TRYPANOSOMA;

EID: 0036853070     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1102-1041     Document Type: Review

References (81)

1. Pearce, E. J., Scott, P. A. & Sher, A. In Fundamental immunology (ed. Paul, W.) 1271-1294 (Lippincott-Raven, Philadelphia, 1999).
2. Borst, P. et al. Antigenic variation in trypanosomes. Arch. Med. Res. 27, 379-388 (1996).
3. Nash, T. E. Surface antigenic variation in Giardia lamblia. Mol. Microbiol. 45, 585-590 (2002).
4. Kyes, S., Horrocks, P. & Newbold, C. Antigenic variation at the infected red cell surface in malaria. Annu. Rev. MicrobioL 55, 673-707 (2001).
5. Belkaid, Y. et al. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194, 1497-506 (2001).
6. Hunter, C. & Sher, A. In Immunology of Infectious Diseases (eds. Kaufman, S., Sher, A. & Ahmed, R.) 111-126 (ASM Press, Washington DC, 2001).
7. Joiner, K. A. Complement evasion by bacteria and parasites. Annu. Rev. Microbiol. 42, 201-230 (1988).
8. Norris, K. A., Bradt, B., Cooper, N. R. & So, M. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor. J. Immunol. 147, 2240-2247 (1991).
9. Norris, K. A. Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance. Infect. Immun. 66, 2460-2465 (1998).
10. Puentes, S. M., Da Silva, R. P., Sacks, D. L., Hammer, C. H. & Joiner, K.A. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9. J. Immunol. 145, 4311-4316 (1990).
11. McConville, M. J., Turco, S. J., Ferguson, M. A. & Sacks, D. L. Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage. EMBO J. 11, 3593-3600 (1992).
12. Brittingham, A. et al. Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J. Immunol. 155, 3102-3111 (1995).
13. Mosser, D. M. & Edelson, P. J. The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmanio promastigotes. J. Immunol. 135, 2785-2789 (1985).
14. Spath, G. F. et al. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc. Natl. Acad. Sci. USA 97, 9258-9263 (2000).
15. Joshi, P. B., Kelly, B. L., Kamhawi, S., Sacks, D. L. & McMaster, W. R. Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Mol. Biochem. Parasitol 120, 33-40 (2002).
16. Raper, J., Portela, M. P., Lugli, E., Frevert, U. & Tomlinson, S. Trypanosome lytic factors: novel mediators of human innate immunity. Curr. Opin. Microbiol. 4, 402-408 (2001).
17. Hajduk, S. L. et al. Lysis of Trypanosoma brucei by a toxic subspecies of human high density lipoprotein. J. Biol. Chem. 264, 5210-5217 (1989).
18. Smith, A. B., Esko, J. D. & Hajduk, S. L. Killing of trypanosomes by the human haptoglobin-related protein. Science 268, 284-286 (1995).
19. Raper, J., Fung, R., Ghiso, J., Nussenzweig, V. & Tomlinson, S. Characterization of a novel trypanosome lytic factor from human serum. Infect. Immun. 67, 1910-1916 (1999).
20. De Greef, C. & Hammers, R. The serum resistance-associated (SRA) gene of Trypanosoma brucei rhodesiense encodes a variant surface glycoprotein-like protein. Mol. Biochem. Parasitol 68, 277-284 (1994).
21. Xong, H. V. et al. A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell 95, 839-846 (1998).
22. Milner, J. D. & Hajduk, S. L. Expression and localization of serum resistance associated protein in Trypanosoma brucei rhodesiense. Mol. Biochem. Parasitol. 104, 271-283 (1999).
23. Sibley, L. D. & Andrews, N. W. Cell invasion by un-palatable parasites. Traffic 1, 100-106 (2000).
24. Mordue, D. G., Desai, N., Dustin, M. & Sibley, L. D. Invasion by Toxoplasma gondii establishes a moving junction that selectively excludes host cell plasma membrane proteins on the basis of their membrane anchoring. J. Exp. Med. 190, 1783-1792 (1999).
25. Lingelbach, K. & Joiner, K. A. The parasitophorous vacuole membrane surrounding Plasmodium and Toxoplasma: an unusual compartment in infected cells. J. Cell Sci. 111, 1467-1475 (1998).
26. Andrews, N. W, Abrams, C. K., Slatin, S. L. & Griffiths, G. A T. cruzi-secreted protein immunologically related to the complement component C9: evidence for membrane pore-forming activity at low pH. Cell 61, 1277-1287 (1990).
27. Hall, B. F., Webster, P., Ma, A. K., Joiner, K. A. & Andrews, N. W. Desialylation of lysosomal membrane glycoproteins by Trypanosoma cruzi: a role for the surface neuraminidase in facilitating parasite entry into the host cell cytoplasm. J. Exp. Med. 176, 313-325 (1992)
28. Ming, M., Ewen, M. E. & Pereira, M. E. Trypanosome invasion of mammalian cells requires activation of the TGF-β signaling pathway. Cell 82, 287-296 (1995).
29. Rittig, M. G. & Bogdan, C. Leishmania-host-cell interaction: complexities and alternative views. Parasitol. Today 16, 292-297 (2000).
30. Alexander, J. & Russell, D. G. The interaction of Leishmania species with macrophages. Adv. Parasitol. 31, 175-254 (1992).
31. Courret, N. et al. Biogenesis of Leishmania-harbouring parasitophorous vacuoles following phagocytosis of the metacyclic promastigote or amastigote stages of the parasites. J. Cell Sci. 115, 2303-2316 (2002).
32. Desjardins, M. & Descoteaux, A. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J. Exp. Med. 185, 2061-2068 (1997).
33. Dermine, J. F., Scianimanico, S., Prive, C., Descoteaux, A. & Desiardins, M. Leishmania promastigotes require lipophosphoglycan to actively modulate the fusion properties of phagosomes at an early step of phagocytosis. Cell Microbiol. 2, 115-126 (2000).
34. Ilg, T., Demar, M. & Harbecke, D. Phosphoglycan repeat-deficient Leishmania mexicana parasites remain infectious to macrophages and mice. J. Biol. Chem. 276, 4988-4997 (2001).
35. Nathan, C. & Shiloh, M. U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 97, 8841-8848 (2000).
36. Schwarzer, E. et al. Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment. J. Exp. Med. 176, 1033-1041 (1992).
37. Schwarzer, E., Turrini, F., Giribaldi, G., Cappadoro, M. & Arese, P. Phagocytosis of P. falciparum malarial pigment hemozoin by human monocytes inactivates monocyte protein kinase C. Biochim. Biophys. Acta 1181, 51-54 (1993).
38. Moore, K. J., Labrecque, S. & Matlashewski, G. Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction. J. Immunol. 150, 4457-4465 (1993).
39. Olivier, M., Brownsey, R. W. & Reiner, N. E. Defective stimulus-response coupling in human monocytes infected with Leishmania donovani is associated with altered activation and translocation of protein kinase C. Proc. Natl. Acad. Sci. USA 89,7481-7485 (1992).
40. Descoreaux, A., Matlashewski, G. Turco, S. J. Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan. J. Immunol. 149, 3008-3015 (1992).
41. McDowell, M. A. & Sacks, D. L. Inhibition of host cell signal transduction by Leishmania: observations relevant to the selective impairment of IL-12 responses. Curr. Opin. Microbiol. 2, 438-443 (1999).
42. Piedrafita, D. et al. Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans. Eur. J. Immunol. 29, 235-244 (1999).
43. Nandan, D. & Reiner, N. E. Attenuation of γ interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat 1. Infect. Immun. 63, 4495-4500 (1995).
44. Blanchette, J., Racette, N., Faure, R., Siminovitch, K. A. & Olivier, M. Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-γ-triggered Jak2 activation. Eur. J. Immunol. 29, 3737-3744 (1999).
45. Forget, G. et al. Role of host phosphotyrosine phosphatase SHP-1 in the development of murine Leishmaniasis. Eur. J. Immunol. 31, 3185-3196 (2001).
46. Marth, T. & Kelsall, B. L. Regulation of interleulkin-12 by complement receptor 3 signaling. J. Exp. Med. 185, 1987-1995 (1997).
47. Giese, N. A. et al. Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J. Exp. Med. 186, 1535-1546 (1997).
48. Xu, X. et al. Down-regulation of IL-12 p40 gene in Plasmodium berghei-infected mice. J. Immunol. 167, 235-241 (2001).
49. Butcher, B. A., Kim, L., Johnson, P. F. & Denkers, E. Y. Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-κB. J. Immunol. 167, 2193-2201 (2001).
50. Shapira, S., Speirs, K., Gerstein, A., Caamano, J. & Hunter, C. A. Suppression of NF-κB activation by infection with Toxoplasma gondii. J. Infect. Dis. 185 (Suppl.) 66-72 (2002).
51. Dobbin, A., Smith, N. C. & Jonson, A. M. Heat shock protein 70 is a potential virulence factor in murine Toxoplasma infection via immunomodulation of host NF-κB and nitric oxide. J. Immunol. 169, 958-965 (2002).
52. Neyer, L. E. et at Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect. Immun. 65, 1675-1682 (1997).
53. + T cells and accompanied by over-production of IL-12, IFN-γ and TNF-α. J. Immunol. 157, 798-805 (1996).
54. Omer, F. M., Kurtzhals, J. A. & Riley, E. M. Maintaining the immunological balance in parasitic infections: a role for TGF-β? Parasitol. Today 16, 18-23 (2000).
55. Kane, M. M. & Mosser, D. M. The role of IL-10 in promoting disease progression in Leishmaniasis. J. Immunol. 166, 1141-1147 (2001).
56. Barral, A. et al. Transforming growth factor β as a virulence mechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. USA 90, 3442-3446 (1993).
57. Luder, C. G., Gross, U. & Lopes, M. F. Intracellular protozoan parasites and apoptosis: diverse strategies to modulate parasite-host interactions. Trends Parasitol. 17, 480-486 (2001).
58. Moore, K. J., Turco, S. J. & Matlashewski, G. Leishmania donovani infection enhances macrophage viability in the absence of exogenous growth factor. J. Leukoc. Biol. 55, 91-98 (1994).
59. Nash, P. B. et al. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J. Immunol. 160, 1824-1830 (1998).
60. Freire-de-Lima, C. G. et al. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403, 199-203 (2000).
61. von Stebut, E., Belkaid, Y., Jakob, T., Sacks, D. L. & Udey, M. C. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J. Exp. Med. 188, 1547-1552 (1998).
62. Marovich, M. A., McDowell, M. A., Thomas, E. K. & Nutman, T. B. IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process. J. Immunol. 164, 5858-5865 (2000).
63. Gorak, P. M., Engwerda, C. R. & Kaye, P. M. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur. J. Immunol. 28, 687-695 (1998).
64. Subauste, C. S. & Wessendarp, M. Human dendritic cells discriminate between viable and killed Toxoplasma gondii tachyzoites: dendritic cell activation after infection with viable parasites results in CD28 and CD40 ligand signaling that controls IL-12-dependent and -independent T cell production of IFN-γ. J. Immunol. 165, 1498-505 (2000).
65. Scanga, C. A. et al. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 168, 5997-6001 (2002).
66. Urban, B. C. & Roberts, D. J. Malaria, monocytes, macrophages and myeloid dendritic cells: sticking of infected erythrocytes switches off host cells, Curr. Opin. Immunol. 14, 458-465 (2002).
67. Urban, B. C. et al. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 400, 73-77 (1999).
68. Urban, B. C., Willcox, N. & Roberts, D. J. A role for CD36 in the regulation of dendritic cell function. Proc. Natl. Acad. Sci. USA 98, 8750-8755 (2001).
69. Newbold, C. et al. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am. J. Trop. Med. Hyg. 57, 389-398 (1997).
70. Rogerson, S. J. et al. Cytoadherence characteristics of Plasmodium falciparum-infected erythrocytes from Malawian children with severe and uncomplicated malaria. Am. J. Trop. Med. Hyg. 61, 467-472 (1999).
71. Van Overtvelt, L. et al. Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules. Infect. Immun. 67, 4033-4040 (1999).
72. Brodskyn, C. et al. Glycoinositolphospholipids from Trypanosoma cruzi interfere with macrophages and dendritic cell responses. Infect. Immun. 70, 3736-3743 (2002).
73. Jebbari, H., Stagg, A. J., Davidson, R. N. & Knight, S. C. Leishmania major promastigotes inhibit dendritic cell motility in vitro. Infect. Immun. 70, 1023-1026 (2002).
74. Ponte-Sucre. A., Heise, D. & Moll, H. Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine Langerhans cells. Immunology 104, 462-467 (2001).
75. Konecny, P. et al. Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro. Eur. J. Immunol. 29, 1803-1811 (1999).
76. 4 T cells in vivo. J. Immunol. 167, 4534-4542 (2001).
77. Bennett, C. L., Misslitz, A., Colledge, L., Aebischer, T. & Blackburn, C. C. Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotes. Eur. J. Immunol. 31, 876-883 (2001).
78. McDowell, M. A., Marovich, M., Lira, R., Braun, M. & Sacks, D. Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p7O secretion is strain and species dependent. Infect. Immun. 70, 3994-4001 (2002).
79. Turco, S. J., Spath, G. F. & Beverley, S. M. Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species. Trends Parasitol. 17, 223-226 (2001).
80. Reis e Sousa, C. et al. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity 11, 637-647 (1999).
81. Alberti, J., Hieny, S., Reis e Sousa, C., Serhan, C. N. & Sher. A. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nature Immunol. 3, 76-82 (2002).